10 analysts have expressed a variety of opinions on Skyward Specialty SKWD over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 3 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $64.3, along with a high estimate of $72.00 and a low estimate of $57.00. This upward trend is apparent, with the current average reflecting a 6.81% increase from the previous average price target of $60.20.
Exploring Analyst Ratings: An In-Depth Overview
A comprehensive examination of how financial experts perceive Skyward Specialty is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $72.00 | $67.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $67.00 | $57.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $66.00 | $57.00 |
| Mark Hughes | Truist Securities | Raises | Buy | $70.00 | $61.00 |
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $65.00 | $60.00 |
| Alex Scott | Barclays | Raises | Overweight | $64.00 | $63.00 |
| Andrew Andersen | Jefferies | Lowers | Hold | $59.00 | $62.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Lowers | Outperform | $57.00 | $62.00 |
| Alex Scott | Barclays | Raises | Overweight | $63.00 | $53.00 |
| Reni Benjamin | Citizens Capital Markets | Maintains | Market Outperform | $60.00 | $60.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Skyward Specialty. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Skyward Specialty compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Skyward Specialty's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Skyward Specialty's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Skyward Specialty analyst ratings.
Get to Know Skyward Specialty Better
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
Skyward Specialty: Delving into Financials
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Skyward Specialty's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 25.26%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Skyward Specialty's net margin excels beyond industry benchmarks, reaching 12.72%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Skyward Specialty's ROE excels beyond industry benchmarks, reaching 5.11%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Skyward Specialty's ROA excels beyond industry benchmarks, reaching 1.08%. This signifies efficient management of assets and strong financial health.
Debt Management: Skyward Specialty's debt-to-equity ratio is below the industry average at 0.14, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Significance of Analyst Ratings Explained
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
